[Is myoglobin a marker of cardiac graft rejection?]

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

ESMO open·2026

18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.

Breast cancer research : BCR·2025

Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort.

ESMO open·2025

Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.

Cancer epidemiology·2025

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.

ESMO open·2024

Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.

Cancer treatment and research communications·2023

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026

Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026

Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026

Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.

Presse medicale (Paris, France : 1983)·2026

Donor lymphocyte infusion as immune modulation after pediatric allogeneic transplantation.

Blood immunology & cellular therapy·2026

Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation.

Frontiers in immunology·2026

Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?

Journal of cardiac failure·2026

Early Results of Beating-Heart Transplantation After Thoraco-Abdominal Normothermic Regional Perfusion in Controlled Donation After Circulatory Death Donors.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Persistent expression of recipient-type ABH antigen following ABO-incompatible stem cell transplantation despite complete donor-type chimerism.

Blood cell therapy·2026

[Pancreatic atrophy and pancreatic exocrine insufficiency after allogeneic hematopoietic stem cell transplantation: a case report and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

Related Experiment Videos

[Is myoglobin a marker of cardiac graft rejection?]

Related Concept Videos

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.

Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort.

Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.

Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Artificial intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Artificial Intelligence in medical research and publishing: Progress, risks, and future perspectives.

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.

Donor lymphocyte infusion as immune modulation after pediatric allogeneic transplantation.

Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation.

Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?

Early Results of Beating-Heart Transplantation After Thoraco-Abdominal Normothermic Regional Perfusion in Controlled Donation After Circulatory Death Donors.

Persistent expression of recipient-type ABH antigen following ABO-incompatible stem cell transplantation despite complete donor-type chimerism.

[Pancreatic atrophy and pancreatic exocrine insufficiency after allogeneic hematopoietic stem cell transplantation: a case report and literature review].

Related Experiment Videos

[Is myoglobin a marker of cardiac graft rejection?]

Related Concept Videos

Related Articles